Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.

Source:http://linkedlifedata.com/resource/pubmed/id/8211217

Download in:

View as

General Info

PMID
8211217